Back

Clinical validation of a novel high-sensitivity cardiac troponin I assay for early diagnosis of acute myocardial infarction

3 March 2018 (12:20 - 12:30)
Organised by:
Congress Presentation Part of: Controversies in patients with NSTEMI Acute Coronary Syndromes: Biomarkers ACVC Premium Access Acute Cardiovascular Care 2018

About the speaker

Photo
Professor Jasper Boeddinghaus

Heartcenter Bonn, University Hospital Bonn, Bonn (Germany)

4 More presentations in this session

Presentation thumbnail
All patients without ST elevation but with troponin elevation after CPR should undergo urgent coronary angiography - PRO.
Doctor M. Noc (Ljubljana, SI)
Slides Video
Presentation thumbnail
All patients without ST elevation but with troponin elevation after CPR should undergo urgent coronary angiography - CONTRA.
Professor U. Zeymer (Ludwigshafen, DE)
Slides Video
Presentation thumbnail
The very elderly (> 80 years) with NSTEMI should be treated with an invasive strategy - PRO.
Doctor S. Savonitto (Lecco, IT)
Slides Video
Presentation thumbnail
The very elderly (> 80 years) with NSTEMI should be treated with an invasive strategy - CONTRA.

Access the full session

Session thumbnail
Controversies in patients with NSTEMI

The Event

Event poster

Acute Cardiovascular Care 2018

3 March 2018 12:20 CET
You may be interested in
thumbnail
Congress Presentation
2 September 2019
thumbnail
Congress Session
High-sensitivity cardiac troponin in acute coronary syndromes: novel assays, pathways, and clinical decision support
28 August 2026
thumbnail
Congress Presentation
2 September 2019
thumbnail
Congress Presentation
Diagnostic and prognostic evaluation of novel biomarkers compared to esc 0/1-hour and 0/3-hour algorithms in patients with suspected non-ST-elevation myocardial infarction
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources